4//SEC Filing
Vizirgianakis Stavros G. 4
Accession 0001235802-22-000113
CIK 0001453593other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 4:48 PM ET
Size
8.0 KB
Accession
0001235802-22-000113
Insider Transaction Report
Form 4
Vizirgianakis Stavros G.
Director
Transactions
- Purchase
Warrant
2022-10-07+566,214→ 566,214 totalExercise: $0.48From: 2022-10-07Exp: 2027-08-25→ Common Stock (566,214 underlying) - Purchase
Common Stock, $0.000001 par value
2022-10-07$0.48/sh+2,264,861$1,087,133→ 5,850,716 total
Footnotes (4)
- [F1]These shares were issued in a second and final tranche of a private placement pursuant to a securities purchase agreement by and among Xtant Medical Holdings, Inc. and several accredited investors.
- [F2]Includes 70,776 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date.
- [F3]This warrant was issued in a second and final tranche of a private placement pursuant to the securities purchase agreement by and among Xtant Medical Holdings, Inc. and several accredited investors.
- [F4]This total does not include a warrant to purchase 878,770 shares of common stock issued on August 25, 2022. Such warrant was immediately exercisable as of the date of issuance and previously reported by the Reporting Person on a Form 4 filed with the Securities and Exchange Commission on August 26, 2022.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
Related Parties
1- filerCIK 0001559834
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 4:48 PM ET
- Size
- 8.0 KB